Unless you’ve been living under a rock, it’s likely you’ve seen all the monkeypox headlines in the stock market recently. Health authorities worldwide are actively looking for a way effective ways to stop the monkeypox outbreak. With that, investors have turned their attention to monkeypox stocks.
The World Health Organization (WHO) reported that Monkeypox is a rare viral disease comparable to smallpox but considered clinically less severe. Also, because it’s a viral disease, vaccination may be the best option to defend against it.
In detail, the resurgence of the disease could enable routine vaccinations for people globally. As well as Monkeypox vaccine manufacturers, antiviral drugmakers and protective equipment manufacturers could be poised to significantly benefit. If you’re keen on investing in the monkeypox sector, here are three monkeypox stocks to keep an eye on in the stock market today.
This post appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.